Advancing Drug Discovery with Cutting-Edge AI & Team Synergy: Fabrice Chouraqui, CEO of Cellarity
Update: 2024-08-28
Description
Synopsis:
Step into the future of biotech as host Rahul Chaturvedi delves into an exclusive conversation with Fabrice Chouraqui, CEO of Cellarity, as he unveils the groundbreaking ways AI is revolutionizing drug discovery. Fabrice will take you behind the scenes of Cellarity’s trailblazing approach, revealing how their pioneering technology is accelerating drug development and creating a synergy-driven powerhouse. Tune in for a front-row seat to the next era of biotech innovation and gain exclusive insights from a leader at the cutting edge of the industry.
Biography:
Fabrice Chouraqui is CEO-partner of Flagship Pioneering and CEO of Cellarity. Cellarity is a Flagship-backed company developing game-changing medicines that are unreachable with traditional methods of drug discovery. By harnessing the power of AI and single-cell omics data, Cellarity’s approach allows them to see disease biology others can’t. The Cellarity platform links biology and chemistry to multi-omics data and enables the design of medicines against cellular dysfunction – an approach applicable to a vast array of diseases to offer new hope to patients in need.
Fabrice is an experienced global pharmaceutical executive with a passion for driving the progress of medical sciences and bringing innovation to patients. He has deep experience across the business spectrum, from R&D to commercial leadership, business development and investor communications. Fabrice has led the launch of breakthrough treatments in a number of areas, including oncology, immunology, neuroscience and cardiovascular. Prior to Cellarity, Fabrice was president of the U.S. Pharmaceuticals business for Novartis, where he was credited with transforming the organization to adapt to a new market environment and turning around its performance. He also represented Novartis on the board of BIO.
Fabrice earned an MBA from INSEAD in France and a Doctorate in Pharmacy, a Post-Graduate Degree in Quality Assurance of Medicines, and a MSc in Biological and Medicinal Sciences from University of Paris V. Born in Paris, France, he is fluent in English and French.
Step into the future of biotech as host Rahul Chaturvedi delves into an exclusive conversation with Fabrice Chouraqui, CEO of Cellarity, as he unveils the groundbreaking ways AI is revolutionizing drug discovery. Fabrice will take you behind the scenes of Cellarity’s trailblazing approach, revealing how their pioneering technology is accelerating drug development and creating a synergy-driven powerhouse. Tune in for a front-row seat to the next era of biotech innovation and gain exclusive insights from a leader at the cutting edge of the industry.
Biography:
Fabrice Chouraqui is CEO-partner of Flagship Pioneering and CEO of Cellarity. Cellarity is a Flagship-backed company developing game-changing medicines that are unreachable with traditional methods of drug discovery. By harnessing the power of AI and single-cell omics data, Cellarity’s approach allows them to see disease biology others can’t. The Cellarity platform links biology and chemistry to multi-omics data and enables the design of medicines against cellular dysfunction – an approach applicable to a vast array of diseases to offer new hope to patients in need.
Fabrice is an experienced global pharmaceutical executive with a passion for driving the progress of medical sciences and bringing innovation to patients. He has deep experience across the business spectrum, from R&D to commercial leadership, business development and investor communications. Fabrice has led the launch of breakthrough treatments in a number of areas, including oncology, immunology, neuroscience and cardiovascular. Prior to Cellarity, Fabrice was president of the U.S. Pharmaceuticals business for Novartis, where he was credited with transforming the organization to adapt to a new market environment and turning around its performance. He also represented Novartis on the board of BIO.
Fabrice earned an MBA from INSEAD in France and a Doctorate in Pharmacy, a Post-Graduate Degree in Quality Assurance of Medicines, and a MSc in Biological and Medicinal Sciences from University of Paris V. Born in Paris, France, he is fluent in English and French.
Comments
Top Podcasts
The Best New Comedy Podcast Right Now – June 2024The Best News Podcast Right Now – June 2024The Best New Business Podcast Right Now – June 2024The Best New Sports Podcast Right Now – June 2024The Best New True Crime Podcast Right Now – June 2024The Best New Joe Rogan Experience Podcast Right Now – June 20The Best New Dan Bongino Show Podcast Right Now – June 20The Best New Mark Levin Podcast – June 2024
In Channel